Quest for Growth...3 FY 2012 results and performance Quest for Growth Key figures: •Return on...
Transcript of Quest for Growth...3 FY 2012 results and performance Quest for Growth Key figures: •Return on...
1
Quest for Growth
Press & Analyst Meeting
25 January 2013
2
Agenda
FY 2012 results and performance Quest for Growth
Comments on quoted portfolio
Comments on unquoted portfolio
Questions and Answers
3
FY 2012 results and performance Quest for Growth
Key figures:
•Return on equity per share: + 17 % since 31 December 2011
•Net Asset Value per share at December 31st 2012: € 9.26 (December 31st 2011: € 7.90).
•Net profit for the fiscal year: + € 15,701,811 (+ € 1.36 per share) against a loss of - € 13,313,623
(- € 1.15 per share) for the previous fiscal year
•Share price at December 31st 2012: € 5.70 (December 31st 2011: € 4.75) or a increase of 20 %
•Discount of the share price versus Net Asset Value: 38.4 % at December 31st 2012
(39.9 % at December 31st 2011).
•New investment in Capricorn ICT ARKIV: + € 7,500,000 (€ 1,875,000 paid in capital).
•Additional investments in unquoted companies (AC Capital, Anteryon, Capricorn Co-Investments, Cartagenia,
Kiadis, Prosonix en TC Land Expression) for a total amount of € 3,533,987
Stock Price
31/12/2012 31/12/2012 30/11/2012 31/12/2011
5.70 EUR 9.26 EUR 9.09 EUR 7.90 EUR
Number of shares 11,529,950 11,529,950 11,529,950
Source: Estimate by Capricorn Venture Partners NV
Net asset value/share
Discount of the share price versus Net Asset Value: 38.42%
4
FY 2012 results and performance Quest for Growth Added value per sector per share
5
FY 2012 results and performance Quest for Growth Added value per asset class per share
6
Quest for Growth NAV Results from 1/01/2005 until 31/12/2012
7
Quest for Growth NAV Evolution loss carried forward since 2007
8
Quest for Growth share price 3 year total shareholders return
9
Quest for Growth share price Discount to Net Asset Value: 38,4 %
10
Quest for Growth share price Portfolio composition and market capitalisation at 31/12/2012
11
Quest for Growth share price Net exposure quoted equities
12
Distribution of the portfolio by sector
at 31/12/2012
Software & Diensten19.5% Technologie
Hardware10.9%
Halfgeleiders2.9%
Medische Uitrusting &
Diensten13.0%
Farma & Biotech10.0%Electrical &
Engineering19.5%
Materialen3.3%
Fondsen & gediversifieerde Ondernemingen
15.1%
Andere sectoren3.4%
Cash & andere activa2.4%
13
Agenda
FY 2012 results and performance Quest for Growth
Comments on quoted portfolio
Comments on unquoted portfolio
Questions and Answers
14
Portfolio quoted Strong equity markets in 2012
15
Portfolio quoted Equity market environment: economic outlook is mixed
ISM Manufacturing Index & US recessions (NBER) IFO index
source : ISM, NBER, IFO, Bloomberg, Capricorn Venture Partners
16
Portfolio quoted Equity market environment:
Detailed analysis with close contact to companies
Company contacts (Capricorn quoted team)
17
Portfolio quoted Transactions 2012 – stocks introduced / removed
IN OUT
Wacker Chemie SMA Solar
Stratec Biomedical Mobotix
Wacker Chemie
Saft Groupe
Rhön-Klinikum
SAP Stratec Biomedical
Rhön-Klinikum
Leguide.com
Docdata
MAY
JUNE
JANUARY
FEBRUARY
MARCH
APRIL
IN OUT
LPKF
Unit4
Fresenius SE
Tomra
Transics
ptf. with earnout
NOVEMBER
DECEMBER
JULY
AUGUST
SEPTEMBER
OCTOBER
18
Portfolio quoted Transactions 2012 – Q4
19
• In December 2012, QfG acquired a portfolio of quoted companies
• Portfolio includes 13.5% stake in 4Energy
• Subject to earnout agreement
• Net valuation at 31/12/2012: € 646,874 (0.5% of NAV)
Portfolio quoted Shares quoted companies subject to an earn-out agreement
20
Portfolio quoted Top 10 holdings
country sector/activity% NAV
31/12/12
Econocom Belgium IT infrastructure management 4.4%
EVS Belgium digital image-processing systems for TV broadcasters 4.2%
Arcadis Netherlands engineering consultancy 4.2%
Andritz Austria plant engineering for hydro power, pulp & paper, ... 4.1%
Nemetschek Germany building software 3.5%
United Drug Ireland healthcare services 3.4%
Umicore Belgium materials technology 3.3%
Imtech Netherlands technical services 2.9%
Gerresheimer Germany glass and plastic products for pharma packaging 2.6%
Init Germany telematics for public transport 2.5%
21
Portfolio quoted Valuations of portfolio companies are still reasonable
12 month forward P/E of portfolio companies at 31/12/2012 (excl. unprofitable cos.)
source: Factset, Capricorn Venture Partners
22
Portfolio quoted Dividend yields
2013e dividend yield of portfolio companies at 31/12/2012 (excl. unprofitable cos.)
source: Factset, Capricorn Venture Partners
23
Portfolio quoted Financial strength of portfolio companies
Net debt/EBITDA 2012e of portfolio companies at 31/12/2012 (excl. unprofitable cos.)
source: Factset, Capricorn Venture Partners
24
Portfolio quoted Strong 2012 performance
2012 portfolio company returns in l.c., excl. trading positions (held < 3 m)
source : Bloomberg, Capricorn Venture Partners , QfG quoted (e) is estimate excluding costs and cash , (I) = return since
introduction, (O) return until removal from portfolio
25
Agenda
FY 2012 results and performance Quest for Growth
Comments on quoted portfolio
Comments on unquoted portfolio
Questions and Answers
26
Portfolio unquoted Value adjustments not assigned to a specific company
In the unquoted portfolio value adjustments for a total of - € 2.86 million were booked in a separate
line. These value adjustments were booked mainly out of fear that certain portfolio companies,
almost in need of refinancing, will have to go to the market with a lower valuation because of the
deteriorating economic situation and the more difficult funding climate that goes with it.
Total Financial Assets - Shares € 103,483,604 96.89%
Depreciation unquoted companies € -2,858,018 -2.68%
Total Financial Assets – Shares after depreciation € 100,625,586 94.22%
27
Portfolio unquoted Follow on investments (direct investments)
• AC Capital 22/06/2012 € 200,039.50
27/12/2012 € 168,817.76
• Anteryon 12/01/2012 € 63,440.00
25/09/2012 € 85,000.00
• Capricorn Cleantech co-investments € 535,955.40
• Cartagenia 22/10/2012 € 625,000.60
• Kiadis Pharma 12/11/2012 € 499,996.54
• Prosonix 05/10/2012 £ 525,650.00
• TC Land 11/05/2012 € 701,333.54
28
• On 18 December 2012, the Capricorn ICT Arkiv was set up with a capital of €15 million for a
period of 10 (+1) years. Quest for Growth invested € 7.5 million.
• The BoD of the Capricorn ICT Arkiv consists of Prof Em Guy Mannaerts (Independent Chairman),
Pamica/ Michel Akkermans (for Quest for Growth), Wouter Winnen (for Ark-M) and Jos B. Peeters
(for Capricorn Venture Partners).
• The investment strategy of the Capricorn ICT Arkiv:
• Geography: Flanders
• Sector: ICT with main focus on Digital Healthcare & Big Data
• Stage: Early Stage
• Investment amount: €500k to €1.5 million (max 20% of fund per portfolio company)
Portfolio unquoted Capricorn ICT ARKIV
29
Broad band & High speed connections
anywhere everywhere
digital innovation in healthcare
Elderly people and chronic disease sufferers wanting to keep an active high quality lifestyle
Healthy people looking to collect, store and analyse personal health
data (“the quantified Self”)
Ageing population and increased burden of chronic diseases
Growing shortage of healthcare workers
Ever more lengthy and costly development cycles for new
medicines
New information and communication technologies Informed patients demanding
high quality, personalized treatment and care and companion diagnostics Unsustainable costs are leading to
healthcare reforms
Push
Pull Right environment
Portfolio unquoted Capricorn ICT ARKIV
Key drivers supporting the Digital Healthcare strategy
30
Portfolio unquoted Capricorn ICT ARKIV
Targeted Investment Areas
• Secure management of clinical information
• Workflow management and clinical decision support
Tools for healthcare providers
• Large scale image processing, computer-aided-detection, semantic reasoning
•Extracting appropriate information out of massive data sets
•Decision support
Tools for healthcare professionals
•Electronic health information networks
•Tools for massive data collection and data mining tools to address policy questions
Tools for healthcare authorities
•Telemedicine and health portals
•Personal wearable and portable communication systems, wireless networks and sensors
Tools for patients and citizens
•Management of massive amounts of data at all stages of research and development of new drugs and therapies
Tools for Pharma & Biotech
31
Portfolio unquoted Capricorn ICT ARKIV
Big Data as a ‘big’ part of Digital Healthcare
• Most digital healthcare companies are by definition data-driven businesses
• Big Data refers to
• The collection, management and analyis of massive (‘big’) data sets
• Any dataset that is too large for a typical database software tool to store,
manage and analyze
• Any body of information that is so big it cannot be analyzed directly for
profitable use in its raw form
• Massive dat sets or combined data sets that are being put to use in new ways
32
Portfolio unquoted Capricorn ICT ARKIV
Investment strategy
• Complying with Arkimedes rules & legislation
• Support innovative companies in early phase of development
• Preference for significant shareholding position and possibility of impacting company strategy
• Series A and series B as majority of initial investments including opportunities in :
• spin-offs from universities and research centres
• spin-outs from corporates
• Initial investment amount from ~€ 500k up to € 1.5 million
33
Portfolio unquoted Capricorn ICT ARKIV
Team
Jos B. Peeters
Katrin Geyskens
Marc Lambrechts
Frank Bulens
34
Portfolio unquoted
Unquoted companies:
ICT
Unquoted companies:
Health-tech
Unquoted companies:
Cleantech
(co-investments)
Venture Funds:
Capricorn Cleantech
Fund
Venture Funds:
Capricorn Health-tech
Fund
Venture funds:
Other funds
Venture Funds:
Capricorn ICT ARKIV
35
Quest for Growth Shareholders structure
Financial & Investment
Management Group, Ltd
15.04%
Belfius Bank12.09%
KBC Asset Management
3.55%
Board members6.24%
Market63.07%
36
Financial calendar 2012
37
Agenda
Introduction
FY 2012 results and performance Quest for Growth
Comments on quoted portfolio
Comments on unquoted portfolio
Questions and Answers
38
Thank you for your attention!